SINOVAC

Challenging last mile for China's vaccine push after zero-Covid retreat

Health risk analysis firm Airfinity has predicted as many as 2.1 million Covid fatalities at current immunity levels. The company modelled its projections on an outbreak in Hong Kong this year, the fifth wave of the virus in the city, when vaccine hesitancy among older people was a major factor in the high death toll. Of the more than 10,500 deaths in that wave, 67 percent were unvaccinated. And more than 95 percent of the dead were aged 60 and above, according to the government. The median age was 86 years.

More in SINOVAC

Extra ammo in the offing against Covid-19

SAGE has also recommended giving booster doses to all people above 60 who have been administered either China’s Sinovac or Sinopharm vaccines — both two-dose vaccines — irrespective of whether their immune systems are robust or weak. SAGE also said that a different vaccine “may also be considered based on vaccine supply and access considerations.”
Sinovac booster shot reverses drop in antibody activities against Delta-study

The study comes amid concerns about the Chinese vaccine's efficacy against Delta, which has become the dominant variant globally and is driving a surge in new infections even in the most vaccinated countries.
US donates 2.5 million Moderna COVID-19 vaccine doses to Pakistan

Charge d' Affaires at the US embassy here Angela P. Aggeler said the vaccines, which arrived at Islamabad International Airport, would save lives and help Pakistan emerge from the COVID-19 crisis, which had devastated so many families and communities in both countries.
WHO decision challenges West to recognize Chinese vaccines

In addition to vaccines by Pfizer-BioNTech, Moderna Inc., AstraZeneca and Johnson & Johnson, the WHO has also given the green light to the two Chinese jabs, made by Sinovac and Sinopharm.
China's Coronavac safe for upto 3-yr-old: Lancet

China earlier this month, authorised the emergency use of CoronaVac, for children aged between 3 and 17 year.
Indonesia examines use of Sinovac, Pfizer vax for kids

China has approved the emergency use of its Sinovac vaccine for children as young as three-year-old, while the US has green-lighted the Pfizer jab for those as young as 12.
Indonesia's doctors becoming patients after administration of China's Sinovac COVID-19 vaccine

Since the pandemic began, 401 doctors in Indonesia have died, the risk mitigation team of the Indonesian Medical Association said on Friday. At least 20 doctors were fully vaccinated with Sinovac.
EMA may not enforce 50% efficacy threshold for Covid vax

EMA said it will consider the benefits and the risks demonstrated by the vaccine and come up with a decision on whether the vaccine can be approved or not.
China to offer Covid-19 vaccine to children as young as three

Since the coronavirus first emerged in central China, Beijing has mostly managed to bring the country's outbreak under control and has administered over 777 million vaccine doses after a sluggish start.
China authorises CoronaVac Covid-19 vaccine for children above 3 yrs

But when the vaccine will be put into (emergency) use and starting from what age in the group has yet to be decided.
BB, Play The A Game: Bharat Biotech’s Covaxin must play a far larger role in India’s vaccination drive

India’s truly atmanirbhar, made-by-Bharat Biotech (BB) vaccine, Covaxin, is yet to secure WHO’s Emergency Use Listing. This, when Sinovac became the second Chinese vaccine after Sinopharm to get global approval.